PharmaLytica 2018 Showcases the Latest in Quality Assurance, Technology, Quality Culture and Regulatory & Compliance Standards for the Pharmaceutical Sector

News provided by

UBM India Pvt. Ltd.

10 Aug, 2018, 16:55 IST

HYDERABAD, India, August 10, 2018 /PRNewswire/ --

A premier industry event in South India by UBM India 

UBM India, the organisers of CPhI / P-MEC India, the leading global pharma trade show and conference, today hosted the 5th edition of PharmaLytica 2018 in Hyderabad at the HITEX Exhibition Center. The two day event was inaugurated  by Chief Guest - Dr. Preeti Meena IAS, Director, Drugs Control Administration, Hyderabad; Guest of Honours - Mr. Uday Bhaskar Reddy, Director General, Pharmaceuticals Export Promotion Council (PHARMEXCIL); Dr. P V  Appaji, Director General Emeritus, Pharmaceuticals Export Promotion Council (PHARMEXCIL); Mr.Avinash Talwar, Director & Head, Global Sourcing (Strategic & Plant) Dr.Reddy's Laboratories Ltd, Dr. R B Smarta, MD, Interlink Marketing Consultancy, Mr. Yogesh Mudras, Managing Director, UBM India and Mr. Rahul Deshpande, Group Director, UBM India amidst an industry gathering.

     (Logo: https://mma.prnewswire.com/media/675607/UBM_Logo.jpg )

     (Logo: https://mma.prnewswire.com/media/726649/PharmaLytica_2018.jpg )

     (Photo: https://mma.prnewswire.com/media/729194/Inauguration_Pharmalytica_5th_edition.jpg )

     (Photo: https://mma.prnewswire.com/media/729195/Lamp_Lighting_Cermony_Pharmalytica.jpg )

PharmaLytica enables the pharmaceutical community procure the current industry trends, innovations and conduct business with Analytical, Laboratory, Machinery, Packaging and other allied Industries. The expo is well supported by associations, including Pharmexcil, Confederation of Indian Pharmaceutical Industry (CiPi) and Indian Drug Manufacturers' Association (IDMA).

In the current edition, PharmaLytica is witnessing participation  from over 150 exhibitors  from across the country including notable industry players such as Kirloskar, Standard Group of Companies, Borosil Glass Works, Bry-Air Asia,  Rotomark Innovations, Control Print, Gandhi Automation, Leistung Engineering, Mack Pharmatech, Domino Printech, Autocal Solutions, FLIR Systems, Helios Concrew, Kirloskar Pneumatics, S.K. Pharma Machinery, NPM Machinery, Goel Scientific, GMM Pfaudler, ELGI Equipments, First Source Lab, Apex Chromatography, Valfit Engineers, Integrated Cleanroom Technology,  Dumra Machines, Sigma Scientific Glass, among many others.

Looking ahead, from 2019, the expo is set to grow and further expand its reach into the Western region with its strong pharma market by hosting PharmaLytica for the first time in Mumbai. While targeting the South-West market with sectors such as Lab & Analytical, Pharma Machinery & Packaging, PharmaLytica will also launch API and Excipients zone to continue it's pre-eminence in this region. This will enhance the exhibition profile as a one stop shop for all end-to-end Pharma solutions under one roof.

Speaking at the launch of the 5th edition of PharmaLytica in Hyderabad, Mr. Yogesh Mudras, Managing Director, UBM India said, "The Indian Pharma economy has been lauded for its rapid growth in recent decades. Within this market, Analytical, Bio-technology, Lab equipments, Pharma Machinery and Pharma Packaging sectors in India are set for amplification owing to quality, research, regulatory and environmental compliances. Therefore, the need of the hour for the Indian pharmaceutical players is to achieve maximum efficiency from the potential of today's landscape with better product and service offerings. At PharmaLytica, every participant gets an opportunity to pick up on the latest industry trends and innovations as well as network with the Pharma business community offering each other a value proposition. The conference that is being held on the sidelines of the expo, seeks to deepen understanding of the changing landscape in the sector to enable responses to the ongoing market trends."

"Given our growing and unparalleled offering in the Pharma domain, we are pleased to announce PharmaLytica' s move to Mumbai in 2019, aiming to add immense value to the strong Western market in addition to the Southern one," he further added. 

Speaking at the occasion, Mr. Uday Bhaskar Reddy, Director General, Pharmaceuticals Export Promotion Council (PHARMEXCIL) said, "In FY 2017-18, Indian Pharma exports grew to USD 17.26 billion. One of the key development to notice is, despite 8% negative growth witnessed in the US market, we still grew positive by 2.92%. There are potential markets to explore like China, South Africa and CIS markets and even if negative growth continues in the US market, the Indian Pharma companies should be confident and focus on growth and explore opportunities in the potential markets."

A series of insightful sessions and panel discussions convened by industry experts are being organized to discuss the trending subjects in Quality Assurance, Technology, Quality Culture and Regulatory & Compliance Standards in the Pharmaceutical Sector. The conference focuses on the growth phase, challenges and how the industry can again truly distinguish itself in the global pharma industry in the years to come.

Day One (10th August) - 'Quality Culture - Revolutionizing Dynamics of Quality Assurance' 

Session 1 - 'A Smart Pharma Manufacturing for Operational Excellence; Latest in Pharmaceutical, Analytical Lab' - Dr. P V Appaji, Former DG, Pharmexcil

Speakers - Dr. Devraj Rambhau, Director - Technical, Pulse Pharma, Dr. Vishwas Sovani, Founder Director, Pharma wisdom and Mr. M Radhakrishnan, Head-HR , Apex Lab, Chennai

  • The presentation (by Dr. P V Appaji) focused on manufacturing set up required in the pharmaceutical facility to ensure quality product and the importance of human resource as an essential part of quality assurance and how to deal with the HR aspect for quality assurance
  • The discussion among the speakers revolved around - (1) Innovative Process Intensification for Continuous API Manufacture - from Concept to Industrial scale, (2) Healthy inputs for healthy products - Medical view and (3) Quality Management Vs Quality Culture - Role of HR

Session 2 - How Technology Provide the Edge for Quality Assurance - Mr. Rajesh Rathi, International Society for Automation; Control infotech, USA

Speakers - Mr. Subbarao V Kattamuri, Head , Aztec India and Mr. Vijay Kirpalani, President, Flow Chemistry Society, India

  • The presentation (by Mr. Rajesh Rathi, International Society for Automation; Control infotech, USA) focused on the automation of all the manual work in the pharmaceutical sector, known as pharmacy informatics, is based on the principles of IT systems. Among many other functions pharma companies need informatics for crossing the quality chasm and preventing errors. IT, like in any other field, can also give a boost to quality assurance in pharma.
  • The discussion among the speakers revolved around - (1) Future Perspective of Quality Culture through Technology and (2) Data Integrity for Quality Culture

Session 3 (i) - Effectively managing HR to control cost, but assuring Quality - Mr. Satish Rajkondawar, Technology Consultant, Pharma

Speakers - Dr. Nagarjuna Akula, Vice President Quality , Shanta Biotech and Ganesh Balakrishnan, Partner, Deloitte Hanskins & Sells, LLP

  • The presentation (by Mr. Satish Rajkondawar, Technology Consultant, Pharma) focused on improvement in the machines, equipment and manufacturing processes and introduction of new parameters and benchmarks done for quality improvement & assurance involves cost
  • The discussion among the speakers revolved around - (1) Balancing between cost and Quality and (2) Is cost a barrier in Quality Culture?

Session 3 (ii) -  Quality Culture Parameters - Concept & Practice - Dr. R B Smarta, Managing Director, Interlink Marketing Consultancy

Speakers - Nilesh Dhamorikar, MD, QBD Research & Development Lab and Mr. Prajwal Bhat, Achila Laboratories

  • The presentation (by Dr. R B Smarta, Managing Director, Interlink Marketing Consultancy) focused on implementing & popularising the quality culture in Indian Pharma is the lack of a mechanism to measure the quality culture outcome. Quality culture articulation & development is a new industry challenge and it is of paramount importance to set such parameters and only then the quality culture will become of the manufacturing processes in all pharma manufacturing facilities
  • The discussion among the speakers revolved around - (1) Change in  Regulatory expectations in audit and (2) Benchmarking parameters for quality culture

Day Two (11th August) - 'Regulatory & Pricing - A Challenge for Pharma Sector' 

Speakers - Mr. Yognandan Pandya, Associate Director, Strategic Marketing & External Affairs, USP India, Dr. Eswara Reddy - DCGI and Dr. Shubhro K Ghosh, Group Leader, Patient Access Service, Novartis Healthcare

  • The discussion among the speakers would revolve around - (1) Indian pharma - Need for and current focus on Skill building and Quality Culture and (2) Balancing Pharmaeconomics

Session 1 - Is Regulatory Compliance much more than GMP? - Ganadhish Kamat, Executive VO & Head, Global Quality organisation, Dr Reddy's Laboratory

Speakers - Shri Nilesh Gandhi, Assistant Commissioner, FDA, Govt of Maharashtra and Dr. Linga Rao, President - Technical Affairs, Natco

  • The presentation (by Ganadhish Kamat, Executive VO & Head, Global Quality organisation, Dr Reddy's Laboratories ltd) would focus on  Quality culture, regulatory compliance, good manufacturing Practices (GMPs) and cost & pricing of products all being interwoven factors, one affecting the other in some way or the other.
  • The discussion among the speakers would include - (1) Regulatory Mechanism for Ensuring Quality and (2) Does GMPs make companies complacent?

Panel Discussion -

Regulatory, Pricing & Patients - Equilibrium - will be moderated by Utkarsh Palnitkar, Partner, KPMG / Dr R B Smarta, Managing Director, Interlink Marketing Consultancy

Dignitaries - Dr. Preeti Meena IAS, Director, Drugs Control Administration, Telangana, Shri Nilesh Gandhi, Assistant Commissioner, FDA, Govt of Maharashtra, Sri M.B.R. Prasad, Director, Drugs Control Administration, Andhra Pradesh, Ms Binita Kundu, AR Strategist, Global Regulatory Affairs, Pfizer Healthcare India, and Mr. Hasin Solmaz, GM , LightHouse Worldwide Solutions, Turkey.

To know more about the event and register for a free entry to the event, visit http://www.ubmindia.in/pharmalytica

About UBM Asia 

UBM Asia recently became part of Informa PLC, a leading B2B information services group and the largest B2B Events organiser in the world. Please visit http://www.ubm.com/asia for more information about our presence in Asia.

About PharmaLytica: 

PharmaLytica is organised by UBM, which in June 2018 combined with Informa PLC to become a leading B2B information services group and the largest B2B Events organiser in the world.

Please visit http://www.ubm.com/india for more information about our presence in India.

Media Contact:
Mili Lalwani
[email protected]
+91-9833279461
UBM India

Roshni Mitra
[email protected]
UBM India